oral semaglutide cardiovascular outcomes soul trial results 2024 2025 SELECT soul trial oral semaglutide cardiovascular

Availability in India and Mumbai depends on regulatory approval and trials

At Power, we believe in using data responsibly to help you find the right clinical trials without compromising your privacy

free base - Crystalline vs

Last year belonged to the realm of Pfizer's COVID-19 small molecule treatments, while this year is dominated by GLP-1 injectable and oral therapies

A 2024 review in the Journal of Clinical Investigation found no increased risk of pancreatitis or pancreatic cancer with long-term GLP-1 use

Our anti-inflammatory supplement helps fight the free radicals found in the environment responsible for premature aging of the skin and the cells